Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.46 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CNR2 | P34972 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALB | P02768 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluene SCHEMBL5404912 | 0.92 | TDP1 (0.53) | CTBP2L3MBTL1TDP1LTB4RLTB4R2 | |
| SCHEMBL4432977 | 0.83 | CTBP2 (0.46) | CTBP2L3MBTL1NPC1RAB9AHPGD | |
| SCHEMBL10567198 | 0.83 | CA2 (0.56) | HPGDTDP1POLBAPEX1LTB4R | |
| SCHEMBL14340565 | 0.83 | ALDH1A1 (0.48) | HPGDTDP1POLBAPEX1KMT2A | |
| SCHEMBL15920608 | 0.83 | HDAC4 (0.44) | TDP1POLBAPEX1HDAC4HDAC6 | |
| SCHEMBL1973647 | 0.83 | CA2 (0.56) | CTBP2NPC1RAB9ALMNAHDAC4 | |
| SCHEMBL24835513 | 0.82 | LTB4R (0.49) | CTBP2L3MBTL1NPC1RAB9AHPGD | |
| SCHEMBL8143899 | 0.81 | CYP2D6 (0.46) | TDP1POLBAPEX1KDM4EOPRK1 | |
| SCHEMBL14959151 | 0.81 | TDP1 (0.62) | CTBP2TDP1POLBAPEX1KMT2A | |
| SCHEMBL15920640 | 0.81 | CA1 (0.45) | RAB9ATDP1POLBAPEX1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203915-A1 | Process for the preparation of solifenacin | DIPHARMA FRANCIS S.R.L. (IT) | 2009-08-13 | — | — | US | claimed |
| EP-2088148-A2 | \"Process for the preparation of solifenacin\ | Dipharma Francis S.r.l. (IT) | 2009-08-12 | — | — | EP | claimed |
| US-11940729-B2 | Photosensitive composition, negative photosensitive composition, pixel division layer and organic EL display device | TORAY INDUSTRIES, INC. (JP) | 2024-03-26 | — | — | US | disclosed |
| US-20230127537-A1 | PHOTOSENSITIVE COMPOSITION, NEGATIVE PHOTOSENSITIVE COMPOSITION, PIXEL DIVISION LAYER AND ORGANIC EL DISPLAY DEVICE | TORAY INDUSTRIES, INC. (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20220177443-A1 | SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2022-06-09 | — | — | US | disclosed |
| WO-2022095989-A1 | P300 INHIBITORS AND USE THEREOF IN MEDICINE | 贝达药业股份有限公司 | 2022-05-12 | — | — | WO | disclosed |
| WO-2020117759-A1 | SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-06-11 | — | — | WO | disclosed |
| WO-2019136022-A1 | PERIODONTAL DISEASE THERAPY | NEW YORK UNIVERSITY (US) | 2019-07-11 | — | — | WO | disclosed |
| US-20180085327-A1 | Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity | ACADIA PHARMACEUTICALS INC. | 2018-03-29 | — | — | US | disclosed |
| US-9481670-B2 | Triazine compounds | SPHAERA PHARMA PTE. LTD. (SG) | 2016-11-01 | — | — | US | disclosed |
| US-9266834-B2 | 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors | Janssen Pharmaceuticals, Inc. (US) | 2016-02-23 | — | — | US | disclosed |
| US-4655843-A | Silane diimidic tetracarboxylic perylene dyes and composite pigments | MONTEDISON S.P.A. (IT) | 1987-04-07 | — | — | US | disclosed |
| EP-0204842-A1 | NODULAR COPOLYMERS FORMED OF ALPHA-OLEFIN COPOLYMERS COUPLED BY NON-CONJUGATED DIENES. | EXXON RESEARCH ENGINEERING CO (US) | 1986-12-17 | — | — | EP | disclosed |
| EP-0204840-A1 | MOLECULAR WEIGHT DISTRIBUTION MODIFICATION IN TUBULAR REACTOR | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-12-17 | — | — | EP | disclosed |
| US-4613667-A | PAINTS, ENAMELS, PLASTICS, INSK | MONTEDISON S.P.A. (IT) | 1986-09-23 | — | — | US | disclosed |
| WO-1986003756-A1 | MOLECULAR WEIGHT DISTRIBUTION MODIFICATION IN TUBULAR REACTOR | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-07-03 | — | — | WO | disclosed |
| WO-1986003755-A1 | NODULAR COPOLYMERS FORMED OF ALPHA-OLEFIN COPOLYMERS COUPLED BY NON-CONJUGATED DIENES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-07-03 | — | — | WO | disclosed |
| US-4540753-A | COORDINATION CATALYST | EXXON RESEARCH & ENGINEERING CO. (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0140688-A2 | Silane perylene dyes, composite pigments obtainable therefrom, and processes for preparing the same | Montedison S.p.A. (IT) | 1985-05-08 | — | — | EP | disclosed |
| EP-0129414-A2 | Narrow MWD alpha-olefin copolymers | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177443-A1 | SMALL MOLECULE DEGRADERS OF HELIOS AND METHODS OF USE | IKZF2, IKZF1, IKZF3 | CTBP2 406/4885L3MBTL1 2499/4885NPC1 2462/4885 |
| US-20090203915-A1 | Process for the preparation of solifenacin | OPRL1, CHRNE, OPRK1 | CTBP2 3403/4885L3MBTL1 4765/4885NPC1 3633/4885 |
| US-20180085327-A1 | Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity | SLC6A4, HTR4, GPR34 | CTBP2 3450/4885L3MBTL1 1939/4885NPC1 962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.